Peginterferon beta-1a for treating relapsing–remitting multiple sclerosis – guidance (TA624)
NICE recommend peginterferon beta‑1a, within its marketing authorisation, as an option for treating relapsing–remitting multiple sclerosis in adults.
Source:
National Institute for Health and Care Excellence